[HTML][HTML] Early initiation of temozolomide therapy may improve response in aggressive pituitary adenomas
Introduction Aggressive pituitary adenomas (APAs) are, by definition, resistant to optimal
multimodality therapy. The challenge lies in their early recognition and timely management …
multimodality therapy. The challenge lies in their early recognition and timely management …
Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas
L Das, N Gupta, P Dutta, R Walia… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Aggressive pituitary adenomas (APAs) are, by definition, resistant to optimal
multimodality therapy. The challenge lies in their early recognition and timely management …
multimodality therapy. The challenge lies in their early recognition and timely management …
[HTML][HTML] Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas
L Das, N Gupta, P Dutta, R Walia, K Vaiphei… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Methods This was a single-center study of all patients with APAs who received at least 3
cycles of temozolomide (150–200 mg/m 2). Their baseline clinico-biochemical and …
cycles of temozolomide (150–200 mg/m 2). Their baseline clinico-biochemical and …
[PDF][PDF] Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas
L Das, N Gupta, P Dutta, R Walia, K Vaiphei… - Front. Endocrinol. 12 …, 2021 - academia.edu
Methods: This was a single-center study of all patients with APAs who received at least 3
cycles of temozolomide (150–200 mg/m2). Their baseline clinico-biochemical and …
cycles of temozolomide (150–200 mg/m2). Their baseline clinico-biochemical and …
Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas.
L Das, N Gupta, P Dutta, R Walia, K Vaiphei… - Frontiers in …, 2021 - europepmc.org
Methods This was a single-center study of all patients with APAs who received at least 3
cycles of temozolomide (150-200 mg/m 2). Their baseline clinico-biochemical and …
cycles of temozolomide (150-200 mg/m 2). Their baseline clinico-biochemical and …